Tg Therapeutics (TGTX) Total Debt Growth (3y) (2013 - 2026)
Tg Therapeutics (TGTX) Total Debt Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Total Debt Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
6.94% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Tg Therapeutics |
7.71 Bn |
7.06 Bn |
171.41 Mn |
97.65% |
| Date | Value |
|---|
| Mar 31, 2026 |
97.65% |
| Dec 31, 2025 |
51.15% |
| Sep 30, 2025 |
51.09% |
| Jun 30, 2025 |
52.61% |
| Mar 31, 2025 |
53.82% |
| Dec 31, 2024 |
53.36% |
| Sep 30, 2024 |
148.04% |
| Jun 30, 2024 |
64.21% |
| Mar 31, 2024 |
49.83% |
| Dec 31, 2023 |
49.61% |
| Sep 30, 2023 |
49.39% |
| Jun 30, 2023 |
49.17% |
| Mar 31, 2023 |
48.95% |
| Dec 31, 2022 |
34.91% |
| Sep 30, 2022 |
35.27% |
| Jun 30, 2022 |
34.22% |
| Mar 31, 2022 |
33.47% |
| Dec 31, 2013 |
-84.30% |
